Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I/II Trial of 4 Prime-boost Combinations of HIV Vaccine Candidates
NCT02038842Phase 2Completed
- Sponsor
- ANRS
- Start
- Mar 2014
- Primary completion
- Oct 2015
- Modality
- Prophylactic Vaccines, Viral Vectors, Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of MVA-B, LIPO-5, GTU-MultiHIV B clade vaccine in human immunodeficiency virus infection (HIV), sponsored by ANRS. Started Mar 2014; status: completed.
02
Drugs
MVA-BLIPO-5GTU-MultiHIV B clade vaccine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT02038842.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02038842.